Changes in use of 17-OHPC after the PROLONG trial: a physician survey.

Itamar D FuttermanLaura GilroyNawras ZayatKimen BalhotraJeremy WeedonHoward Minkoff

Published in: Journal of perinatal medicine (2023)

Providers have made significant changes in their counseling regarding progesterone use for patients at risk for preterm birth after the publication of the PRLONG trial.

Keyphrases

preterm birth
end stage renal disease
study protocol
newly diagnosed
phase iii
clinical trial
ejection fraction
phase ii
emergency department
primary care
chronic kidney disease
low birth weight
gestational age
randomized controlled trial
smoking cessation
cross sectional
open label
estrogen receptor
hiv testing